Fresenius Kabi

Supporting you in
the fight against

Supporting you in
the fight against

A lifesaving match

A lifesaving match

A lifesaving match

Facing cancer together

Facing cancer together

Facing cancer together

Developing biosimilars to make

biologics more accessible

Developing biosimilars to make

biologics more accessible

Developing biosimilars to make

biologics more accessible

Delivering lifesaving medicines
and advanced technologies

Answering the challenges
medical professionals face

Supporting you in
the fight against

Supporting you in
the fight against

A lifesaving match

A lifesaving match

Facing cancer together

Facing cancer together

Developing biosimilars to make

biologics more accessible

Developing biosimilars to make

biologics more accessible

Delivering lifesaving medicines
and advanced technologies

Answering the challenges
medical professionals face

News

September 7, 2021

Fresenius Kabi provides update on clinical trials for biosimilar candidate Tocilizumab.

Fresenius Kabi and AABB Celebrate 16th Annual Blood Collectors Week

Fresenius Kabi Introduces New Simplist® Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe

Fresenius Kabi Receives Premier Supplier Legacy Award

Lindsey Thomas appointed to ASHP Foundation Board of Directors

Temsirolimus Injection Now Available from Fresenius Kabi

Fresenius Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride Injection in Ready-to-Use Freeflex® Bags

Fresenius Kabi Signs Exclusive U.S. Distribution Agreement with Corvida Medical for the HALO® Closed System Drug-Transfer Device

Fresenius Kabi Introduces First-Ever Generic for Foscavir® (Foscarnet Sodium) Injection

Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter

Fresenius Kabi provides update on clinical trials for biosimilar candidate Tocilizumab.

Fresenius Kabi and AABB Celebrate 16th Annual Blood Collectors Week

Fresenius Kabi Introduces New Simplist® Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe

Fresenius Kabi Receives Premier Supplier Legacy Award

Lindsey Thomas appointed to ASHP Foundation Board of Directors

Temsirolimus Injection Now Available from Fresenius Kabi

Fresenius Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride Injection in Ready-to-Use Freeflex® Bags

Fresenius Kabi Signs Exclusive U.S. Distribution Agreement with Corvida Medical for the HALO® Closed System Drug-Transfer Device

Fresenius Kabi Introduces First-Ever Generic for Foscavir® (Foscarnet Sodium) Injection

Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter

Our Response to COVID-19

We all play a vital role in the fight against COVID-19. Only by working together will we overcome this new disease. Right now, we may need to stand a few feet further apart, but it is more important than ever to all of us at Fresenius Kabi that we stand together.

CAREERS

As a part of Fresenius Kabi, you can enjoy an exciting career, a company culture based on a clear purpose and values, and the knowledge that your work makes a real difference. If you would like to learn more about us, we would love to hear from you.

Our Response to COVID-19

CAREERS

October 8 - 12, 2021
|
San Diego, CA & Virtual

ASA: American Society of Anesthesiologists Annual Meeting

October 16 - 19, 2021
|
Carlsbad, CA

AABB: American Association of Blood Banks

Annual Meeting & Postgraduate Course Website

October 26 - 29, 2021
|
Las Vegas, NV

Asembia Specialty Annual Summit

Summit Website

November 4 - 6, 2021
|
Nashville, TN

NASPGHAN Annual Meeting

November 11 - 13, 2021
|
Atlanta, GA

ANCC: National Magnet Conference and Pathway to Excellence Conference

Conference Website

October 8 - 12, 2021
|
San Diego, CA & Virtual

ASA: American Society of Anesthesiologists Annual Meeting

October 16 - 19, 2021
|
Carlsbad, CA

AABB: American Association of Blood Banks